Professor Graham Packham, Founder
Professor Packham joined the University of Southampton in 2000 and was awarded his readership in 2004. He heads the Apoptosis Research Group, based in the Cancer Research UK funded unit at Southampton General Hospital, which is focused on gene regulation and survival pathways in malignant cells. After securing a First in Biochemistry (University of Leeds) and a PhD (University of London), Graham completed post-doctoral studies at St Jude Children's Hospital (Memphis, USA) where he was recipient of the Martin Morrison Fellowship. In 1995, Graham joined the Ludwig Institute to establish an independent research group with the aim of investigating apoptosis in cancer cells.
Dr A Ganesan, Founder
Dr Ganesan is a Reader in the School of Chemistry at Southampton University. He is an internationally recognized expert in the field of natural-product chemistry. He is a founding member of the Royal Society of Chemistry's High Throughput Chemistry and New Technologies Group and sits on the editorial advisory board of the Journal of Combinatorial Chemistry, and QSAR & Combinatorial Science. He has chaired a number of key scientific conferences, including the 2003 ACS Perspectives and the 2004 Gordon Conference. In 2004, Ganesan became the first chemist to synthesize the complex natural product, Spiruchostatin A.
Dr Paul Townsend, Founder
Dr Townsend is a Reader in Southampton University's School of Medicine. Paul is a graduate of York University and the Imperial Cancer Research Fund (now part of Cancer Research UK). After completing post-doctoral research at Imperial College London and fellowship training at University College London he moved to Southampton in 2004. Paul holds a BBSRC New Investigator Award and British Heart Foundation project grants, amongst others. His research is focused on cell protection mechanisms and signaling pathways in cardiovascular and cancer cells. He is a member of the SEEDA funded London Technology Network Emerging Technology advisory board. He has chaired a number of key scientific conferences including the American Heart Association apoptosis series 2006. He regularly reviews for a number of high-impact journals including Cancer Research, Circulation Research, Cell Death & Differentiation, FASEB Journal, and the Journal of Biological Chemistry.
Karus Therapeutics Ltd
John Fairclough Centre
University of Southampton
Highfield
Southampton
Hampshire SO17 1BJ
United Kingdom